Plain-English translation of NCT06477783 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Multiple Myeloma research guide →This study is watching how well works for people with multiple myeloma — a blood cancer — who have already tried at least three other treatments without success. Researchers want to understand how effective this medication is and what side effects patients experience over two years of treatment. By carefully tracking your progress, they hope to learn whether this new option truly helps people in your situation.
Multiple myeloma is a serious blood cancer, and many patients run out of treatment options after trying multiple medications. This medication represents a new approach, and doctors need real-world evidence from actual patients to understand whether it works better than existing choices and how safe it truly is.
You likely qualify if…
You likely don't qualify if…
You will visit the clinic monthly for the first six months while taking the medication, then every three months after that for up to two years total. At each visit, doctors will check your blood work, assess how you are feeling, and monitor whether your cancer is responding. You will continue this follow-up unless your disease gets worse, you decide to stop, or the study ends — whichever happens first.
AI-generated summary from trial data · Jul 6, 2026 · Not medical advice
Belgium